Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Metzler

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Progress in Clinical and Biological Research|January 1, 1984
Studies on the structure of the beta subform of cytosolic aspartate aminotransferaseC M Metzler
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1988
Commentary to "Linear and Nonlinear System Approaches in Pharmacokinetics. How much do they have to offer? II. The response mapping operator (RMO) approach"C M Metzler
Pharmaceutical Research|December 1, 1987
Assessment of variance in bioavailability studies: comments on the article by McNamara et alC M Metzler
Statistics in Medicine|June 1, 1991
Sample sizes for bioequivalence studiesC M Metzler
Biometrics|June 1, 1974
Bioavailability--a problem in equivalenceC M Metzler
Pharmacology & Therapeutics|January 1, 1981
Estimation of pharmacokinetic parameters: statistical considerationsC M Metzler
Journal of Pharmaceutical Sciences|July 1, 1987
Extended least squares (ELS) for pharmacokinetic modelsC M Metzler
Journal of Clinical Pharmacology|April 1, 1989
Bioavailability/bioequivalence: study design and statistical issuesC M Metzler
The Journal of Infectious Diseases|December 1, 1974
Susceptibility tests of anaerobic bacteria: statistical and clinical considerationsC M Metzler, R M DeHaan
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1978
Curve fitting and modeling in pharmacokinetics: a responseC M Metzler, G L Elfring
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Progress in Clinical and Biological Research|January 1, 1984
Studies on the structure of the beta subform of cytosolic aspartate aminotransferaseC M Metzler
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1988
Commentary to "Linear and Nonlinear System Approaches in Pharmacokinetics. How much do they have to offer? II. The response mapping operator (RMO) approach"C M Metzler
Pharmaceutical Research|December 1, 1987
Assessment of variance in bioavailability studies: comments on the article by McNamara et alC M Metzler
Statistics in Medicine|June 1, 1991
Sample sizes for bioequivalence studiesC M Metzler
Biometrics|June 1, 1974
Bioavailability--a problem in equivalenceC M Metzler
Pharmacology & Therapeutics|January 1, 1981
Estimation of pharmacokinetic parameters: statistical considerationsC M Metzler
Journal of Pharmaceutical Sciences|July 1, 1987
Extended least squares (ELS) for pharmacokinetic modelsC M Metzler
Journal of Clinical Pharmacology|April 1, 1989
Bioavailability/bioequivalence: study design and statistical issuesC M Metzler
The Journal of Infectious Diseases|December 1, 1974
Susceptibility tests of anaerobic bacteria: statistical and clinical considerationsC M Metzler, R M DeHaan
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1978
Curve fitting and modeling in pharmacokinetics: a responseC M Metzler, G L Elfring
Pageof 6